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Abstract
Part 1 of this series focused on factors influencing
payment for patient care services. In Part 2, we review
compensation models for nonpatient activity such as
medical legal reviews, committee participation, and
collaboration with the pharmaceutical industry. Compensation to neurologists in private practice is commonly in the form of guaranteed salary and bonuses.
Salary for neurologists in academic medicine has
changed considerably over the past 3 decades, from
small departments with faculty supported by grants
and volunteer faculty, to large departments with
faculty split between those with research grant support and those focusing on patient care and teaching.
Compensation models in academic medicine range
from straight salary without bonus to straight salary
with personal or shared bonus and salary based on relative value units. Neurol Clin Pract 2015;5:405–411

W

e review compensation models for nonpatient activities such as medical legal
reviews, committee participation, and collaboration with the pharmaceutical
industry.

Vanderbilt University Medical Center (PDD), Nashville, TN; Henry Ford Hospital (GLB), Detroit, MI;
Children’s Hospital Medical Center of Akron (BHC), OH; Texas Neurology (DAE), Dallas; Emory University
(GJE), Atlanta, GA; University of Maryland (BS), School of Medicine, Baltimore; University of Calgary (JRB),
Alberta Children’s Hospital, Canada; and American Academy of Neurology (AB), Minneapolis, MN.
Funding information and disclosures are provided at the end of the article. Full disclosure form information
provided by the authors is available with the full text of this article at Neurology.org/cp.
Correspondence to: peter.donofrio@vanderbilt.edu
Neurology: Clinical Practice

|||

October 2015

Neurology.org/cp

405

ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

Peter D. Donofrio et al.

Committee members are usually perceived as
valued leaders in their community and
participation may open the door to referral
bases and greater participation in
administration decision-making.
Clinical research trials
Clinical research trials can be profitable for the neurologist in private practice and academics,
although investigators may lose money through inexperience in recognizing all of the components of clinical research. Common sources for funding include the NIH, industry, postmarketing projects, and venture and external capital. Neurologists who underestimate the value of
their time and the time of their research collaborators may undercharge for critical aspects of the
research and may complicate the situation by underenrolling the projected number of research
subjects. Ideally, a neurologist interested in pursuing clinical research should choose trials that
complement his or her clinical interests and patient demographics, as well as trials that utilize
the available procedural services within the practice. In an outpatient setting, an investigator
can take advantage of existing staff, space, and supplies. The sharing of available resources leads
to higher compensation for the investigators and facilities that use ancillary services for a component of a research trial, e.g., MRI, EEG, nerve conduction studies, sleep studies, and infusion
of experimental medications. However, budgets for these trials have become lean in recent
years. Even though these trials may improve departmental income, they are not as financially
profitable as they once were.
Clinical trial budgets must include salary support for the principal investigator. Many trial
budgets only include funding for neurologic history and examinations for the physician investigators (PI). A line item with appropriate funding for PI support should always be included in a
clinical trial budget. This pays for administrative oversight and management of the study that is
often overlooked or underestimated at the time the contracts are prepared. A portion of the PI’s
salary should be paid from the trial.
All physician effort associated with the expected tasks must be included in the budget for
training, including attending investigator meetings, protocol review, meeting with representatives of the clinical research organizations, and the study coordinator and other staff participating in the trial. The institutional review board (IRB) submission (application preparation and
IRB fees) should be charged to the sponsor as a nonrefundable cost. IRBs often charge for
amendments and the study sponsor should be held accountable for these payments. These payments should be invoiced when the contract is signed and not returned to the sponsor if research subjects are not enrolled. The sponsor should pay for screening patients who do not
meet criteria for participation.
Nonpatient activity income
Many neurologists derive a portion of their income from activities not directly related to patient
care. These income streams include serving on hospital committees, as speakers for a pharmaceutical company, or as expert witnesses in medical legal cases.
Compensation for serving on a hospital committee is regulated by the Stark and AntiKickback regulations and must be at a fair market value.1 This time away from the office
may prove to be more or less valuable than billing for direct patient activities depending on
the compensation. Nevertheless, the intrinsic value of serving on these committees should
always be considered. Committee members are usually perceived as valued leaders in their
community and participation may open the door to referral bases and greater participation in
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Expert witness and associated consultative
services may be an effective means to augment
income if a neurologist is an established expert
in a defined area of neurology.
administration decision-making. In some hospital compensation models, committee duties
are not reimbursed directly, but the neurologist is given a reduction in their work relative
value unit (RVU) requirement for the years they serve on the committee.
The Physician Payment Sunshine Act, a component of the Patient Protection and Affordable Care Act, requires the public disclosure of speaking and consulting fees.2 Reports of
payments made to physicians in 2013 were published in 2014. This reporting has deterred
some physicians from speaking publicly because of a concern over consumer backlash from
the published display of this information.

Compensation models for private practice
In today’s neurology practices, there are several options for compensating both physician
owners and employed physicians. A straight production model is common in private practice
and some academic and hospital-based practices. Total compensation is calculated from a
formula of revenue dollars plus income from ancillary services minus direct practice expenses
and an allocation of overhead expenses, which will vary by pay period, month, or quarter.
Sometimes, when using this model, a practice will start a new neurologist at a base salary and
add bonus income based on physician effort and other variables that may be linked to the
overall financial success of the practice. Many practices start new neurologists on a guaranteed
base salary for 1–2 years and convert to the payment revenue model in subsequent years.
Some practices use a lower base salary and add incentives based on work RVUs or collections
exceeding a predetermined revenue threshold. Occasionally, groups will set minimum requirements to reach varying compensation levels, such as a minimum number of work RVUs or
a minimum number of appointment hours. This may be most effective when physicians desire
to work a reduced schedule or have other commitments that restrict their ability to work as
many clinic hours as other physicians in the practice. In some practices where the minimum
RVU model is implemented, the neurologist is held accountable for making up the slots of
no-show patients or late cancellations in order to meet the expected RVU requirements for
a given time period.
Business optimization
Efficient operations are critical to maximizing profits. When striving for a lean organization,
changes in the work flow will be necessary. This may involve a top-to-bottom process for evaluating staff and steps to focus on streamlining processes and limiting redundancy. To accomplish this, a physician may consider self-education in the established principles of either Lean or
Six Sigma.3 The tools utilized through either of these methods have been applied to health
care operations with success in streamlining operations and improving care while lowering
costs.
Medical legal activities
Expert witness and associated consultative services may be an effective means to augment income if a neurologist is an established expert in a defined area of neurology. Generally, the
pay rate for medical legal services depends on the type of service rendered. It is common to
charge an hourly fee for the time spent reviewing medical records, preparing expert reports,
and meetings or phone calls. A higher fee may be warranted for depositions and court appearances. Frequent depositions, court appearances, and case reviews during clinic time may lead to
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lost patient revenue, unnecessary staff support costs, loss of ancillary testing revenues, and decreased patient access, all which could affect referring physician and patient satisfaction.

Physician compensation in academic practice
Until about 25–30 years ago, academic neurology employed a relatively small number of
neurologists. Departments often comprised salaried physicians who were primarily involved in
research and who spent little time in patient care, and a separate voluntary staff of independent (private practice) neurologists. If a base salary existed, it was often a teaching stipend
from the medical school or at best a salary equal to that of a basic science faculty member
within the undergraduate/graduate school of the university. It was derived from grant funding, department funds as determined by the department chair or dean, and a previously
agreed-upon percentage of billings or collections earned for patient care.
In the last 2 decades, academic practices have changed considerably. Some faculty have lost
external and university funding for research and have transitioned from laboratory work to clinical activities. The creation of 2 academic tracks has permitted a hierarchy to remain by continuing the traditional academic track, often judged by eternal funding and the quality and number of
publications, and adding a clinical academic track that permits promotion based on teaching and
other services. Some faculty (despite retaining their teaching obligations) in the medical schools
have lost their teaching stipend. Another factor is lost funding from their university or state for
many neurology departments in medical centers. This creates conflict unless the dean and hospital administration, often employed by different corporations, are not fully aligned on the mission of the medical center. These forces require academic neurology departments to become
financially independent and either establish their own cost centers within the hospital system
or join a practice plan with the other clinical departments within the medical center.
Many of the academic medical centers (AMCs) have recruited physicians who were once in
private practice and have spent little time in academic medicine or teaching. These clinicians
bring to the academic department a wealth of patient management experience and skills. In
some instances, these physicians do not move their practice location, but are absorbed into
the academic system that assumes their administrative responsibilities and pays their salary.
These offices serve as satellite locations for the neurology departments. The financial models
that drive salaries of the satellite physicians resemble those in private practice.
Several salary models exist for neurologists employed by AMCs, but many are toward the
fixed salary model, with or without a bonus potential. These are salary models that would seem
foreign to many nonmedical industries. For example, the salary for junior members starts below
that of the most senior members, with the expectation that pay raises occur either gradually over
the years, or in quantum steps that coincide with academic promotions. Each institution has its
own system for pay increases, but in general it takes about 10–15 years to achieve the maximum salary potential. Many AMCs use the American Association of Medical Colleges
compensation surveys as salary benchmarks. This compensation model is unlike other professions, for example, attorneys or accountants, where charges for the service are based on
experience, perceived worth, and prestige. Highly valued attorneys, bankers, and businessmen
are compensated commensurate with their skills, reputation, and ability to attract new business. In medicine, the most senior and internationally renowned physician cannot charge
more for a patient encounter than the least experienced physician. Even though the billing
potential is the same regardless of experience, the senior physicians earn more than junior
physicians, as a reward for experience, reputation in the community and state, and loyalty to
the institution. To some degree, academic medicine is a profession where junior members
support the salary of the senior members of a department. Although it can be argued that this
model has worked well for years, the model may fail if revenue streams from grants, research
revenue, and neurodiagnostic procedures continue to decline. This compensation scheme
may discourage young faculty members who may sense underpayment for their services
and are unwilling to invest the time (in years) to be rewarded for seniority.
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Over decades, most academic neurology departments have differentiated into multiple subspecialties and 2 camps: those that primarily generate revenue from standard evaluation and
management (E&M) patient encounters such as neuro-oncology, general neurology, and
neurocognitive dementia, and those subspecialties whose revenue derives from procedures,
primarily neurophysiology, sleep, and chemodenervation. A neurologist with a saturated
schedule can bill more units of service per time interpreting EEGs and EMGs than performing E&M services. In addition to the work RVUs generated, the technical fees for these
services (typically two-thirds of the total charge), at least historically, provided a substantial
source of revenue to the department or hospital. It is common for those neurologists interpreting EEGs or EMGs full-time to generate 50%–75% more work RVUs per unit of time
than a neurologist performing E&M services. In addition to EEG and EMG revenue, other
procedures that generate both work RVUs and technical RVUs include sleep studies, intraoperative monitoring, and botulinum injections. IV infusion suites for headache management
and treatments for multiple sclerosis and neuropathies can also be lucrative for neurology
departments.
In a private practice setting, a neurologist would generally be engaged in both providing
E&M services for the patient as well as performing and interpreting procedures. However,
in academic practices, the E&M and procedures are disproportionally divided along subspecialty lines. In most academic settings, the salaries for neurologists who perform high-revenuegenerating activities are the same or only slightly higher than those for neurologists with an
equal amount of subspecialty training who are performing mainly E&M services. The rationale for not having a large salary differential for neurologists at the same academic rank is (1)
the nonprocedural neurologists generate many of the referrals for the high reimbursement
studies in a department, (2) most neurologists performing E&M alone would not be able to
generate sufficient revenue to support their salary, and (3) a neurology department would
quickly become embittered and dysfunctional if a large salary difference existed between the
general neurologists and proceduralists. In most academic neurology departments, a symbiosis
exists where the work of junior neurologists supports senior member’s salaries, the nonprocedural neurologists provide the proceduralists patients to study, and the proceduralists generate
incremental revenue sufficient to support their own salaries and other members of the
department.
Several salary models have evolved to compensate neurologists in academic medicine. Those
include straight salary without bonus, salary with personal bonus, salary with a shared bonus,
and salary based on work RVUs. The main characteristics of each are described in the table.
For at least one department, the shared bonus is determined by the number of RVUs generated above a predetermined level as well as agreed-upon academic, educational, and professional goals (B. Soronson, personal communication, 2015). This requires the assignment of
work RVU equivalents for teaching, lectures, publications, and other productive activities with
the source of support coming from general funds of the Department of Neurology. Other
AMCs incorporate research productivity, teaching, internal and external committee effort,
and other criteria established by department leadership into shared bonus calculations. Another
model is to salary physicians in academic departments based on agreed-upon targets (e.g.,
RVUs, publications, grant submissions) and responsibilities (e.g., committees, teaching, administration). In this way, financial incentives would be eliminated and the physicians could
focus on the expected work for the agreed-upon compensation.

Research grant support
For a research enterprise to be successful, research grants and contracts must pay the physician’s
efforts in addition to support for the center and employees. Traditional grants have salary and
fringe benefits allocated to the principal investigator and coinvestigators. A salary cap of
$183,300 currently is mandated by NIH, but this will likely change in the future, usually
in January. If a physician’s salary exceeds this cap, the institution is required to pay the
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Table

Comparison of academic neurology compensation plans

Straight salary without Neurologist has a fixed schedule of patients; employer has predictive
bonus
model for number of show and no-show patients; employer manages
schedule to fill all available slots; neurologist does not have the power to
modify schedule without renegotiating contract
Straight salary with
personal bonus

Base salary and bonus based on productivity above a RVU threshold or
another threshold; neurologist has freedom to attain threshold only or
work diligently to achieve bonus

Straight salary with
shared bonus

Bonus can be divided equally or proportionately among faculty; all
neurologists in department invest in a vision to achieve the bonus; each
member assigned a personal RVU goal

Salary based on RVUs

Resembles plan of a neurologist in private practice; salary based on RVU
production or actual percentage of receivables; failure to attain RVU
production results in cut in salary

RVU 5 relative value unit.

difference between the salary and the cap. For example, if the physician’s salary is $225,000,
and has a 10% research effort ($22,500) and salary support is requested, the grant pays
$18,330 and the institution has to provide $4,170 as a cost share contribution.

Career development or K awards
K awards are offered by the National Institute of Neurological Disorders and Stroke. Most of
these awards currently provide salary support to the awardee of $85,000 to $105,000 per year
and most provide support for fringe benefits. Other sections of NIH offer K awards between
$75,000 and $105,000 toward salary support. Typically K awards require a minimum of 75%
effort focused on the funded research project. The NIH closely scrutinizes faculty effort on
these projects so it is critical the actual effort meets the requirements of the award.
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